TNF-α inhibitors, which are antibodies that lower inflammation in both atherosclerosis and autoimmune illnesses like rheumatoid arthritis, include infliximab, etanercept, and adalimumab (Jacobsson et al., 2005). The gene discussed is TNF; the disease is atherosclerosis.